Treatment of Human Tumor Xenografts with Monoclonal Antibody 806 in Combination with a Prototypical Epidermal Growth Factor Receptor–Specific Antibody Generates Enhanced Antitumor Activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of Human Tumor Xenografts with Monoclonal Antibody 806 in Combination with a Prototypical Epidermal Growth Factor Receptor–Specific Antibody Generates Enhanced Antitumor Activity

Published:2005-09-01 Issue:17 Volume:11 Page:6390-6399
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Perera Rushika M.,Narita Yoshitaka,Furnari Frank B.,Gan Hui K.,Murone Carmel,Ahlkvist Marika,Luwor Rodney B.,Burgess Antony W.,Stockert Elisabeth,Jungbluth Achim A.,Old Lloyd J.,Cavenee Webster K.,Scott Andrew M.,Johns Terrance G.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment;Annual Review of Chemical and Biomolecular Engineering;2024-07-24

2. AGCM-22, a novel cetuximab-based EGFR-targeting antibody-drug-conjugate with highly selective anti-glioblastoma efficacy;Bioorganic & Medicinal Chemistry;2024-03

3. Exploring Novel Therapeutic Opportunities for Glioblastoma Using Patient-Derived Cell Cultures;Cancers;2023-03-02

4. The Internalization and Therapeutic Activity of Antibody Drug Conjugates;Antibody-Drug Conjugates and Cellular Metabolic Dynamics;2023

5. MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations;Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP